Literature DB >> 3097237

The Ro/SSA autoantigen as an immunogen. Some anti-Ro/SSA antibody binds IgG.

M J Mamula, O F Fox, H Yamagata, J B Harley.   

Abstract

The rheumatic disease autoantigen, Ro/SSA, was immunogenic to a rabbit host. The heteroimmune rabbit serum bound the Ro/SSA particle in immunoblots and in an ELISA. Both the rabbit anti-Ro/SSA and a human prototype anti-Ro/SSA serum also bound IgG; and moreover, IgG inhibited both rabbit and human anti-Ro/SSA activity. Anti-IgG activity of the rabbit and human anti-Ro/SSA sera bound Ro/SSA by Western blot and solid-phase assays. In addition, purified Ro/SSA inhibited the anti-IgG activity of the anti-Ro/SSA sera from rabbit and man. Affinity purification of the IgG- and Ro/SSA-binding fractions of the rabbit anti-Ro/SSA demonstrated that both the anti-Ro/SSA and anti-IgG activities were concentrated in these fractions. These data show that Ro/SSA and IgG share epitopes that are bound by anti-Ro/SSA antibody. Inhibition experiments suggest that this antibody is found in most human anti-Ro/SSA autoimmune sera and that the epitope(s) are found in the F(ab')2 fragment of IgG.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097237      PMCID: PMC2188496          DOI: 10.1084/jem.164.6.1889

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Anti-gamma-globulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies.

Authors:  C K OSTERLAND; M HARBOE; H G KUNKEL
Journal:  Vox Sang       Date:  1963 Mar-Apr       Impact factor: 2.144

2.  Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus.

Authors:  G Clark; M Reichlin; T B Tomasi
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

3.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

4.  Monoclonal and polyclonal gamma M rheumatoid factors with anti-di- and anti-trinitrophenyl activity.

Authors:  K Hannestad
Journal:  Clin Exp Immunol       Date:  1969-05       Impact factor: 4.330

5.  Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody.

Authors:  H Yamagata; J B Harley; M Reichlin
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

Review 6.  Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature.

Authors:  R M Watson; A T Lane; N K Barnett; W B Bias; F C Arnett; T T Provost
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

7.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

8.  Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics.

Authors:  J Rauch; H Massicotte; H Tannenbaum
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

9.  Homogenous rabbit 7S anti-IgG with antibody specificity for peptidoglycan.

Authors:  V A Bokisch; J W Chiao; D Bernstein; R M Krause
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

10.  Identification, developmental regulation, and response to heat shock of two antigenically related forms of a major nuclear envelope protein in Drosophila embryos: application of an improved method for affinity purification of antibodies using polypeptides immobilized on nitrocellulose blots.

Authors:  D E Smith; P A Fisher
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

View more
  13 in total

Review 1.  B-cell epitopes of La and Ro autoantigens.

Authors:  S Whittingham
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 2.  Autoantibodies against small cytoplasmic ribonucleoproteins: the anti-Ro/SS-A and anti-La/SS-B autoimmune response. A review of autoantibody detection, autoantigen composition, autoantibody-disease associations and possible etiologic mechanisms.

Authors:  J F Meilof
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

3.  A common autoepitope near the carboxyl terminus of the 60-kD Ro ribonucleoprotein: sequence similarity with a viral protein.

Authors:  R H Scofield; W D Dickey; K W Jackson; J A James; J B Harley
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

4.  The ultrastructural localization of 60-kDa Ro protein and human cytoplasmic RNAs: association with novel electron-dense bodies.

Authors:  A D Farris; F Puvion-Dutilleul; E Puvion; J B Harley; L A Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells.

Authors:  M D Rader; C O'Brien; Y S Liu; J B Harley; M Reichlin
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Characterization of human telomerase complex.

Authors:  S Ramakrishnan; H W Sharma; A D Farris; K M Kaufman; J B Harley; K Collins; G J Pruijn; W J van Venrooij; M L Martin; R Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

7.  Polyclonal human rheumatoid factors cross-reacting with histone H3: characterization of an idiotope on the H3 binding site.

Authors:  T Martin; A M Knapp; S Muller; J L Pasquali
Journal:  J Clin Immunol       Date:  1990-07       Impact factor: 8.317

8.  Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen.

Authors:  B T Kurien; J Newland; C Paczkowski; K L Moore; R H Scofield
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

9.  Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide.

Authors:  T S Lieu; M M Newkirk; J D Capra; R D Sontheimer
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  Antibodies to EYRKK vesicular stomatitis virus-related peptide account only for a minority of anti-Ro60kD antibodies.

Authors:  J G Routsias; M Sakarellos-Daitsiotis; E Detsikas; A G Tzioufas; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.